Patent Oppositions in mixed drugs industry

Explore the competitive field of mixed drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in mixed drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the mixed drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the mixed drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Apr 16, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Combination Therapy For Inhalation AdministrationCHEMO RESEARCHFeb 27, 2026MURGITROYD
Combination Therapy For Inhalation AdministrationCHEMO RESEARCHFeb 26, 2026BRAND MURRAY FULLER
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDFeb 26, 2026DEVA HOLDING
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDFeb 26, 2026DEVA HOLDING
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDFeb 25, 2026ELKINGTON AND FIFE
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 16, 2026ALFRED E TIEFENBACHER
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 13, 2026ZENTIVA KS
Combinations Of A 4-Pyrimidinesulfamide Derivative With Active Ingredients For The Treatment Of Endothelin Related DiseasesIDORSIA PHARMACEUTICALSFeb 13, 2026ELKINGTON AND FIFE
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 12, 2026GENERICS UK
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 10, 2026LANYON OPPOSITIONS

To stay ahead in the competitive mixed drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the mixed drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Apr 16, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY22
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS18
Oct 11, 2023New UseNOVARTIS17
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA13
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE10
Sep 14, 2022Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM10
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
Oct 30, 2019New UseNOVARTIS9
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
Oct 9, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8